Green Bioactives completes £2.6m seed financing to advance its sustainable plant products biomanufacturing platform

Plant Cell Culture experts, Green Bioactives, have raised £2.6 million in order to grow their production and research capabilities as well as expanding the management team.  

Green Bioactives are global leaders in the discovery, development and sustainable production of high-value natural products derived from plant cell cultures. The investment will allow Green Bioactives to launch its first products in the cosmetic and nutraceutical markets later this year.  

Green Bioactives is currently working with several world-leading partners to produce sustainable and economic high value bioactives. These projects include: 

·       A multinational consumer goods company developing and selling products in foods and drinks, home care, personal care and cosmetics. 

·       A multinational biotechnology company developing and selling products for commercial applications in pharmaceuticals, consumer healthcare and agriculture. 

·       A global agricultural solutions company specialising in the development, marketing, and processing of agricultural inputs such as crop protection products, seeds, and fertilizers. 

David McElroy, CEO of Green Bioactives, commented: “This £2.6m seed funding is an incredibly exciting milestone for Green Bioactives, and we’re delighted to have attracted such a strong international investor base – demonstrating the global commercial potential of our plant cell culture - based biomanufacturing platform. The investment comes at a key time for the company, as we prepare for further growth and continue to develop our technology, working towards our goal of becoming the world’s leading supplier of safe, natural and sustainably-sourced plant-derived products.” 

Gary Loake, Chairman and founder of Green Bioactives added:

“We are excited to have received investment from such an experienced national and international line-up of investors. This now enables us to significantly accelerate the development of Green Bioactives. Our proprietary plant cell culture-based biomanufacturing platform will provide sustainable solutions for the supply of high value plant natural products across a range of diverse industrial sectors”. 

 

For more information visit: www.green-bioactives.com  

Valerie Evans